• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含氮双膦酸盐对人法尼基焦磷酸合酶的抑制作用。利用酶突变体阐明活性位点苏氨酸201和酪氨酸204残基的作用。

The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.

作者信息

Tsoumpra Maria K, Muniz Joao R, Barnett Bobby L, Kwaasi Aaron A, Pilka Ewa S, Kavanagh Kathryn L, Evdokimov Artem, Walter Richard L, Von Delft Frank, Ebetino Frank H, Oppermann Udo, Russell R Graham G, Dunford James E

机构信息

Botnar Research Centre, Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Science, University of Oxford, Oxford OX3 7LD, UK; Structural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, UK.

Structural Genomics Consortium, University of Oxford, Oxford OX3 7DQ, UK.

出版信息

Bone. 2015 Dec;81:478-486. doi: 10.1016/j.bone.2015.08.020. Epub 2015 Aug 28.

DOI:10.1016/j.bone.2015.08.020
PMID:26318908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4652608/
Abstract

Farnesyl pyrophosphate synthase (FPPS) is the major molecular target of nitrogen-containing bisphosphonates (N-BPs), used clinically as bone resorption inhibitors. We investigated the role of threonine 201 (Thr201) and tyrosine 204 (Tyr204) residues in substrate binding, catalysis and inhibition by N-BPs, employing kinetic and crystallographic studies of mutated FPPS proteins. Mutants of Thr201 illustrated the importance of the methyl group in aiding the formation of the Isopentenyl pyrophosphate (IPP) binding site, while Tyr204 mutations revealed the unknown role of this residue in both catalysis and IPP binding. The interaction between Thr201 and the side chain nitrogen of N-BP was shown to be important for tight binding inhibition by zoledronate (ZOL) and risedronate (RIS), although RIS was also still capable of interacting with the main-chain carbonyl of Lys200. The interaction of RIS with the phenyl ring of Tyr204 proved essential for the maintenance of the isomerized enzyme-inhibitor complex. Studies with conformationally restricted analogues of RIS reaffirmed the importance of Thr201 in the formation of hydrogen bonds with N-BPs. In conclusion we have identified new features of FPPS inhibition by N-BPs and revealed unknown roles of the active site residues in catalysis and substrate binding.

摘要

法尼基焦磷酸合酶(FPPS)是含氮双膦酸盐(N-BPs)的主要分子靶点,N-BPs在临床上用作骨吸收抑制剂。我们通过对突变的FPPS蛋白进行动力学和晶体学研究,调查了苏氨酸201(Thr201)和酪氨酸204(Tyr204)残基在底物结合、催化以及N-BPs抑制作用中的作用。Thr201突变体表明甲基在辅助异戊烯基焦磷酸(IPP)结合位点形成中的重要性,而Tyr204突变揭示了该残基在催化和IPP结合中的未知作用。Thr201与N-BP侧链氮之间的相互作用对于唑来膦酸(ZOL)和利塞膦酸(RIS)的紧密结合抑制很重要,尽管RIS仍能与Lys200的主链羰基相互作用。RIS与Tyr204苯环的相互作用被证明对于维持异构化的酶-抑制剂复合物至关重要。对RIS构象受限类似物的研究再次证实了Thr201在与N-BPs形成氢键中的重要性。总之,我们确定了N-BPs抑制FPPS的新特征,并揭示了活性位点残基在催化和底物结合中的未知作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/e28d3e1ba22d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/7fd594296eb5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/2dccfa0c6eaf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/4e3fb442d998/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/e28d3e1ba22d/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/7fd594296eb5/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/2dccfa0c6eaf/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/4e3fb442d998/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/335a/4652608/e28d3e1ba22d/gr4.jpg

相似文献

1
The inhibition of human farnesyl pyrophosphate synthase by nitrogen-containing bisphosphonates. Elucidating the role of active site threonine 201 and tyrosine 204 residues using enzyme mutants.含氮双膦酸盐对人法尼基焦磷酸合酶的抑制作用。利用酶突变体阐明活性位点苏氨酸201和酪氨酸204残基的作用。
Bone. 2015 Dec;81:478-486. doi: 10.1016/j.bone.2015.08.020. Epub 2015 Aug 28.
2
The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.含氮双膦酸盐作为抗骨质疏松药物的分子机制。
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7829-34. doi: 10.1073/pnas.0601643103. Epub 2006 May 9.
3
Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase.含氮双膦酸盐可以在体内抑制血管生成,而不需要法呢基焦磷酸合酶的参与。
Bone. 2011 Feb;48(2):259-66. doi: 10.1016/j.bone.2010.09.035. Epub 2010 Oct 20.
4
Ternary complex structures of human farnesyl pyrophosphate synthase bound with a novel inhibitor and secondary ligands provide insights into the molecular details of the enzyme's active site closure.人法尼基焦磷酸合酶与新型抑制剂及二级配体结合的三元复合结构,为深入了解该酶活性位点关闭的分子细节提供了线索。
BMC Struct Biol. 2012 Dec 12;12:32. doi: 10.1186/1472-6807-12-32.
5
Farnesyl pyrophosphate synthase: real-time kinetics and inhibition by nitrogen-containing bisphosphonates in a scintillation assay.法尼基焦磷酸合酶:闪烁测定法中的实时动力学及含氮双膦酸盐对其的抑制作用
Assay Drug Dev Technol. 2007 Apr;5(2):205-14. doi: 10.1089/adt.2007.057.
6
Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer.氮杂双膦酸盐(N-BPs)与克氏锥虫法呢基二磷酸合酶同源二聚体的结合。
Proteins. 2010 Mar;78(4):888-99. doi: 10.1002/prot.22614.
7
Structural and thermodynamic basis of the inhibition of Leishmania major farnesyl diphosphate synthase by nitrogen-containing bisphosphonates.含氮双膦酸盐抑制硕大利什曼原虫法尼基二磷酸合酶的结构和热力学基础。
Acta Crystallogr D Biol Crystallogr. 2014 Mar;70(Pt 3):802-10. doi: 10.1107/S1399004713033221. Epub 2014 Feb 22.
8
Computational insights into binding of bisphosphates to farnesyl pyrophosphate synthase.计算洞察双膦酸盐与法呢基焦磷酸合酶的结合。
Curr Med Chem. 2011;18(2):220-33. doi: 10.2174/092986711794088335.
9
Correlation between time-dependent inhibition of human farnesyl pyrophosphate synthase and blockade of mevalonate pathway by nitrogen-containing bisphosphonates in cultured cells.氮杂双磷酸化合物在培养细胞中对人法呢基焦磷酸合酶的时程抑制作用与甲羟戊酸途径阻断的相关性。
Biochem Biophys Res Commun. 2011 Apr 22;407(4):663-7. doi: 10.1016/j.bbrc.2011.03.070. Epub 2011 Mar 21.
10
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.临床使用的含氮双膦酸盐及其他类似物的构效关系:人法尼基焦磷酸合酶的时间依赖性抑制作用
J Med Chem. 2008 Apr 10;51(7):2187-95. doi: 10.1021/jm7015733. Epub 2008 Mar 8.

引用本文的文献

1
Hydroxychloroquine and a low antiresorptive activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects.羟氯喹与一种低抗吸收活性双膦酸盐偶联物通过双重抗吸收和合成代谢作用预防和逆转去卵巢小鼠的骨丢失。
Bone Res. 2024 Sep 5;12(1):52. doi: 10.1038/s41413-024-00352-6.
2
Sclerostin and Wnt Signaling in Idiopathic Juvenile Osteoporosis Using High-Resolution Confocal Microscopy for Three-Dimensional Analyses.使用高分辨率共聚焦显微镜进行三维分析研究特发性青少年骨质疏松症中的硬化蛋白与Wnt信号传导
Children (Basel). 2024 Jul 4;11(7):820. doi: 10.3390/children11070820.
3

本文引用的文献

1
Bisphosphonates: the first 40 years.双膦酸盐:40 年的发展历程。
Bone. 2011 Jul;49(1):2-19. doi: 10.1016/j.bone.2011.04.022. Epub 2011 May 1.
2
The relationship between the chemistry and biological activity of the bisphosphonates.双膦酸盐的化学和生物学活性之间的关系。
Bone. 2011 Jul;49(1):20-33. doi: 10.1016/j.bone.2011.03.774. Epub 2011 Apr 9.
3
Bisphosphonates for postmenopausal osteoporosis.双磷酸盐类药物治疗绝经后骨质疏松症。
Thonzonium bromide inhibits progression of malignant pleural mesothelioma through regulation of ERK1/2 and p38 pathways and mitochondrial uncoupling.
溴化噻唑鎓通过调节ERK1/2和p38信号通路以及线粒体解偶联来抑制恶性胸膜间皮瘤的进展。
Cancer Cell Int. 2024 Jun 29;24(1):226. doi: 10.1186/s12935-024-03400-7.
4
Antimicrobial and Anesthetic Niosomal Formulations Based on Amino Acid-Derived Surfactants.基于氨基酸衍生表面活性剂的抗菌和麻醉型尼莫司汀制剂。
Molecules. 2024 Jun 14;29(12):2843. doi: 10.3390/molecules29122843.
5
Hydroxychloroquine and a low activity bisphosphonate conjugate prevent and reverse ovariectomy-induced bone loss in mice through dual antiresorptive and anabolic effects.羟氯喹啉与低活性双膦酸盐共轭物通过双重抗吸收和合成代谢作用预防并逆转小鼠卵巢切除诱导的骨质流失。
Res Sq. 2024 May 3:rs.3.rs-4237258. doi: 10.21203/rs.3.rs-4237258/v1.
6
Novel bisphosphonate-based cathepsin K-triggered compound targets the enthesis without impairing soft tissue-to-bone healing.新型基于双膦酸盐的组织蛋白酶K触发化合物靶向附着点,而不损害软组织到骨的愈合。
Front Bioeng Biotechnol. 2024 Feb 16;12:1308161. doi: 10.3389/fbioe.2024.1308161. eCollection 2024.
7
Paget's Disease of the Bone and Lynch Syndrome: An Exceptional Finding.骨佩吉特病与林奇综合征:一项特殊发现。
Diagnostics (Basel). 2023 Jun 17;13(12):2101. doi: 10.3390/diagnostics13122101.
8
Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review).双膦酸盐作为生物瓣钙化潜在抑制剂的研究进展(综述)。
Sovrem Tekhnologii Med. 2022;14(2):68-78. doi: 10.17691/stm2022.14.2.07. Epub 2022 Mar 28.
9
Bone tumor-homing nanotherapeutics for prolonged retention in tumor microenvironment and facilitated apoptotic process mevalonate pathway inhibition.用于在肿瘤微环境中长时间滞留并促进凋亡过程的骨肿瘤靶向纳米治疗药物 甲羟戊酸途径抑制
Mater Today Bio. 2023 Feb 23;19:100591. doi: 10.1016/j.mtbio.2023.100591. eCollection 2023 Apr.
10
Design, Synthesis, Molecular Docking, Dynamics and Evaluation of Novel 2-substituted-1-hydroxyethane-1, 1-bis(phosphonic acid) Derivatives as Human Farnesyl Pyrophosphate Synthase Inhibitors with Expected Anticancer Activity.新型2-取代-1-羟基乙烷-1,1-双(膦酸)衍生物作为具有预期抗癌活性的人法尼基焦磷酸合酶抑制剂的设计、合成、分子对接、动力学及评价
Curr Pharm Des. 2023;29(1):48-59. doi: 10.2174/1381612829666221202114947.
Bone. 2011 Jul;49(1):82-8. doi: 10.1016/j.bone.2011.02.011. Epub 2011 Feb 22.
4
Bisphosphonates in oncology.双膦酸盐类药物在肿瘤学中的应用。
Bone. 2011 Jul;49(1):71-6. doi: 10.1016/j.bone.2011.02.003. Epub 2011 Feb 21.
5
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.唑来膦酸对比氯膦酸在多发性骨髓瘤(MRC Myeloma IX)一线治疗中的应用:一项随机对照试验。
Lancet. 2010 Dec 11;376(9757):1989-99. doi: 10.1016/S0140-6736(10)62051-X. Epub 2010 Dec 3.
6
Molecular characterization of a novel geranylgeranyl pyrophosphate synthase from Plasmodium parasites.从疟原虫中鉴定新型香叶基香叶基二磷酸合酶的分子特征。
J Biol Chem. 2011 Feb 4;286(5):3315-22. doi: 10.1074/jbc.M109.027235. Epub 2010 Nov 17.
7
Bisphosphonates in Paget's disease.双膦酸盐在佩吉特病中的应用。
Bone. 2011 Jul;49(1):89-94. doi: 10.1016/j.bone.2010.09.002. Epub 2010 Sep 9.
8
Phaser crystallographic software.相位结晶学软件。
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. doi: 10.1107/S0021889807021206. Epub 2007 Jul 13.
9
Determination of the microscopic equilibrium dissociation constants for risedronate and its analogues reveals two distinct roles for the nitrogen atom in nitrogen-containing bisphosphonate drugs.测定利塞膦酸盐及其类似物的微观平衡解离常数揭示了含氮双膦酸盐药物中氮原子的两种不同作用。
J Med Chem. 2008 Jul 24;51(14):4170-8. doi: 10.1021/jm7015792. Epub 2008 Jul 1.
10
Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging.他汀类药物和氨基双膦酸盐联合治疗可延长人类早衰小鼠模型的寿命。
Nat Med. 2008 Jul;14(7):767-72. doi: 10.1038/nm1786. Epub 2008 Jun 29.